Eli Lilly and Company

Kevin Robert Fales

Donald Paul Matthews

Prabhakar Kondaji Jadhav

Jonathan Edward Green

David Andrew Coates

Timothy Alan Shepherd

Kenneth Jeff Thrasher

Mitchell I Steinberg

Yanping Xu

Timothy A Grese

Michael Gregory Bell

Jefferson Ray McCowan

Edward C R Smith

David Andrew Neel

Quanrong Shen

Jeffrey Michael Schkeryantz

Robert Dean Dally

Zhipei Wu

Matthew John Valli

Timothy Barrett Durham

James Lee Toth

Harold Burns Brooks

Michael Joseph Coghlan

Chong Si

John Rowley Wetterau, Ii

Frank George Njoroge

Kwame Frimpong

Quanrong ' Shen

Dariusz Stanislaw Wodka

Jeffrey Allen Peterson

Jeffrey Alan Peterson

Yangping Xu

Ii Wetterau John Rowley

John Rowley Wetterau Ii

The invention provides compounds of the formula: (A), pharmaceutically acceptable salts, pharmaceutical compositions thereof and methods of using these compounds, salts, or compositions to treat hyperphosphatemia, chronic kidney disease, and/or the cardiovascular disease associated with chronic kidney disease. 

Condensed thiophene derivatives useful as NaPi-IIb inhibitors

1-Oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors.

1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers

The present invention provides a compound of the formula: Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly frailty, osteoporosis, osteopenia, and male and female sexual dysfunction comprising administering to a patient in need thereof an effective amount of a compound of formula (I). 

Tetrahydrocarbazole derivatives useful as androgen receptor modulators

The present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation comprising administering to a patient in need thereof an effective amount of a compound of the formula: or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula I, including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula I.

Tricyclic steroid hormone nuclear receptor modulators

Growing community of inventors

Avon, IN, United States of America

Kevin Robert Fales